Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...

Researchers have made a significant advancement in the field of spinal cord injury research, developing a novel optogenetic mouse model that could lead to improved treatments for limb spasticity.

A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body. Occurring in 80% of stroke ...